
|Articles|September 11, 2015
Kim Statham Ringen on the Importance of Meeting Other Survivors
Author(s)Kim Statham Ringen
Kim Statham Ringen, DVM DACVIM (Oncology), a CURE contributor who is currently surviving stage 4 non-small cell lung cancer, discusses the importance of meeting other cancer survivors.
Advertisement
Kim Statham Ringen, DVM DACVIM (Oncology), a CURE contributor who is currently surviving stage 4 non-small cell lung cancer, discusses the importance of meeting other cancer survivors.
“I know all the statistics — the odds are against me,” Ringen says. “You don’t actually obtain hope until you meet another individual who’s pretty much just like you — same stage, same treatment options — and they’re out four years, five years, six years, seven years.”
Advertisement
Advertisement
Advertisement
Trending on CURE
1
FDA Updates Safety Warnings for Common Chemotherapy Drugs
2
KTX-1001 Elicits Responses in Some With Multiple Myeloma
3
New Combination Treatment Approach Studied in Pancreatic Cancer
4
FDA Removes Use Limitation for Yescarta in Primary CNS Lymphoma
5




